Dinender Kumar
Overview
Explore the profile of Dinender Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hill M, Palace V, Kaur K, Kumar D, Khaper N, Singal P
Exp Clin Cardiol
. 2009 Jul;
10(3):146-53.
PMID: 19641679
Background: Patients surviving myocardial infarction (MI) are at a heightened risk for the development of congestive heart failure. This clinical syndrome has been associated with an antioxidant deficit and elevated...
2.
Singla D, Kumar D, Sun B
Biochem Biophys Res Commun
. 2005 May;
332(1):135-41.
PMID: 15896309
Stem cell therapy holds great promise for the treatment of injured myocardium, but is challenged by a limited supply of appropriate cells. Three different isoforms of transforming growth factor-beta (TGF-beta)...
3.
Kumar D, Kamp T, LeWinter M
Coron Artery Dis
. 2005 Mar;
16(2):111-6.
PMID: 15735404
Many forms of heart disease are associated with the loss of cardiomyocytes both via apoptosis or necrosis, and despite the recent identification of resident cardiac stem cells, the native capacity...
4.
5.
Kumar D, Hacker T, Buck J, Whitesell L, Kaji E, Douglas P, et al.
Coron Artery Dis
. 2005 Jan;
16(1):41-4.
PMID: 15654199
Unlabelled: This study describes the coronary anatomy of C57BL/6 mice and the functional impact of that anatomy on myocardial infarctions induced by ligation of the left coronary artery. In contrast...
6.
Kumar D, Robertson S, Burns K
Mol Cell Biochem
. 2004 May;
259(1-2):67-70.
PMID: 15124909
Diabetic nephropathy is characterized by an early period of renal growth with glomerular and tubular cell hypertrophy, but this is followed by progressive glomerulosclerosis and tubulointerstitial fibrosis, associated with loss...
7.
Kumar D, Zimpelmann J, Robertson S, Burns K
Nephron Exp Nephrol
. 2004 Apr;
96(3):e77-88.
PMID: 15056984
Background/aims: Angiotensin II (Ang II) mediates progressive nephron loss in diabetes and stimulates apoptotic cell death in several tissues. We studied the extent of apoptosis in streptozotocin (STZ) induced diabetic...
8.
Kumar D, Menon V, Ford W, Clanachan A, Jugdutt B
Mol Cell Biochem
. 2004 Mar;
258(1-2):211-8.
PMID: 15030186
Mitogen-activated protein kinases (MAPKs) have been implicated during ischemia-reperfusion (IR) and angiotensin II (AngII) type 2 receptor (AT2R) blockade has been shown to induce cardioprotection involving protein kinase Cepsilon (PKCepsilon)...
9.
Kumar D, Menon V, Ford W, Clanachan A, Jugdutt B
J Cardiovasc Pharmacol Ther
. 2004 Jan;
8(4):285-96.
PMID: 14740078
Background: The stress-responsive mitogen-activated protein kinases (MAPKs) (p38-MAPK, c-Jun NH2-terminal kinase [JNK-1 and JNK-2], and extracellular signal regulated kinases [ERK-1 and ERK-2]) might be involved in angiotensin II (AII)-induced ischemia-reperfusion...
10.
Kumar D, Jugdutt B
J Lab Clin Med
. 2003 Dec;
142(5):288-97.
PMID: 14647032
Cardiomyocyte (CM) apoptosis has been reported in a variety of cardiovascular diseases, including myocardial infarction, ischemia/reperfusion, end-stage heart failure, arrhythmogenic right ventricular dysplasia, and adriamycin-induced cardiomyopathy. The role of CM...